A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS.
Sandercock
P
P
Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland.
Berge
E
E
Dennis
M
M
Forbes
J
J
Hand
P
P
Kwan
J
J
Lewis
S
S
Lindley
R
R
Neilson
A
A
Thomas
B
B
Wardlaw
J
J
D002545:Brain Ischemia / Q000188:drug therapy / Q000191:economics; D003362:Cost-Benefit Analysis; D004059:Diffusion of Innovation; D006801:Humans; D018696:Neuroprotective Agents / Q000191:economics / Q000627:therapeutic use*; D013222:State Medicine / Q000458:organization & administration*; D020521:Stroke / Q000188:drug therapy* / Q000191:economics; D015912:Thrombolytic Therapy / Q000191:economics*; D016896:Treatment Outcome; D006113:United Kingdom
D018696:Neuroprotective Agents